Results 151 to 160 of about 80,362 (282)

Verapamil Sensitive Idiopathic Ventricular Tachycardia in an Infant

open access: bronze, 2003
Jiaan‐Der Wang   +3 more
openalex   +2 more sources

Further Insights Into Anticholinergic Action Informed by Japanese Anticholinergic Risk Scale

open access: yesGeriatrics &Gerontology International, Volume 26, Issue 1, January 2026.
ABSTRACT The increased anticholinergic burden caused by medications in older adults is one of the adverse drug reactions of particular concern, as it can exacerbate the onset of geriatric syndromes or induce cognitive dysfunction, and is also related to the issue of polypharmacy.
Masaki Mogi   +4 more
wiley   +1 more source

Chronopharmacology of verapamil in Stage I-II arterial hypertension

open access: yesКардиоваскулярная терапия и профилактика, 2009
Aim. To compare the pharmacokinetics and pharmacodynamics of verapamil retard, regularly taken by patients  with Stage I-II arterial hypertension (AH). Material and methods. The effects of the administration time (morning vs. evening) on verapamil retard
V. G. Belolipetskaya   +8 more
doaj  

Pacemapping [PDF]

open access: yes, 2005
Pacemapping (PM) is an electrophysiologic technique designed to help locating tachycardia sources by stimulating at different endocardial sites in order to reproduce the clinical tachycardia characteristics.
Moreno, Mauricio   +2 more
core   +2 more sources

Do patients with migraine and obesity receive different treatments? Insights from real‐world data

open access: yesHeadache: The Journal of Head and Face Pain, Volume 66, Issue 1, Page 88-95, January 2026.
Abstract Background Patients with obesity often experience stigma in healthcare, which may lead to underdiagnosis or undertreatment. In the context of pain management, and migraine specifically, patients with obesity are more likely to receive both opioid and non‐opioid analgesics.
Keshet Pardo   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy